Emerging therapies are significantly shifting our landscape for systemic dysfunction. MOTS-c, representing various molecules, present potential possibilities for treating conditions like type two glucose intolerance and weight gain. Although investigations are still in progress , initial findings indicate substantial benefits in blood sugar control